AI-assisted system for diagnosing colorectal polyps during colonoscopy
Prospective Study of ASUS Endoscopy AI Solution- EndoAim Assisting Diagnosis of Colorectal Polyps
This study is testing whether an AI tool can help doctors find more colorectal polyps during colonoscopy to reduce the risk of cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 548 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | China Medical University Hospital Academic / other |
| Locations | 1 site (Taichung, North Dist.) |
| Trial ID | NCT06656312 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the ASUS AI-assisted system, EndoAim, in improving the detection of colorectal polyps during colonoscopy. Participants will be randomly assigned to undergo colonoscopy with or without the assistance of EndoAim, allowing for a comparison of diagnostic outcomes. The study aims to enhance the Adenoma Detection Rate (ADR) and Adenoma Per Colonoscopy (APC) by utilizing AI technology to assist physicians in identifying polyps more accurately. The research addresses the significant issue of missed polyps during colonoscopy, which can lead to increased cancer risk.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 20 or older who are scheduled to undergo a colonoscopy.
Not a fit: Patients with poor bowel cleansing or those who cannot complete the colonoscopy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve polyp detection rates, thereby reducing the risk of colorectal cancer.
How similar studies have performed: Other studies have shown promise in using AI-assisted systems for polyp detection, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 20 or older. 2. Undergoing colonoscopy using the Olympus series endoscopes. 3. Following a low-residue diet and undergoing bowel preparation. Exclusion Criteria: 1. Poor bowel cleansing. Note: Evaluated as Poor or Inadequate according to the Aronchick scale. 2. Incomplete colonoscopy (not reaching the cecum). 3. Use of anticoagulant medications or abnormal coagulation function within the last 5 days.
Where this trial is running
Taichung, North Dist.
- China Medical University Hospital — Taichung, North Dist., Taiwan (Recruiting)
Study contacts
- Principal investigator: Wen-Hsin Huang, MD — China Medical University Hospital
- Study coordinator: Hsing-Hung Cheng, MD
- Email: 017124@tool.caaumed.org.tw
- Phone: +886-975680861
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.